National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 625301

History of Changes from the VAERS Wayback Machine

First Appeared on 3/14/2016

625301
VAERS Form:
Age:16.0
Gender:Female
Location:Colorado
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-03-04
Entered:2016-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Electroencephalogram abnormal, Generalised tonic-clonic seizure, Mental impairment, Nuclear magnetic resonance imaging brain abnormal, Seizure, Computerised tomogram head abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Computerised tomogram, mentally challenged; Electroencephalogram, mentally challenged; Nuclear magnetic resonance imaging, mentally challenged
CDC 'Split Type': WAES1603USA001499

Write-up:Information has been received from a consumer referring to her 16 years old daughter. The patient was not pregnant. The patient had no medical history and drug reactions or allergies. On an unknown date in 2011, the patient was vaccinated with her first dose of GARDASIL (0.5 ml, lot # and expiry date unknown, intramuscular). There was no concomitant therapy reported. In 2011, almost immediately following her first intramuscular injection, the patient experienced grand mal seizures. The patient''s mother also noticed at that time that her daughter''s mental acumen began declining (The patient was previously an honor student in school). On unknown dates, the patient was vaccinated with her second and third dose of GARDASIL (0.5 ml, lot # and expiry date unknown, intramuscular). On an unknown date, the patient''s mother took the patient to a neurologist who ran a battery of tests including electroencephalogram (EEG), nuclear magnetic resonance imaging (MRI) and computerised tomogram (CAT scan). Subsequently, the test results determined the patient was "mentally challenged". In September 2014, the patient was hospitalized at a hospital for 2 days due to severe seizures (started in September 2014). The patient was also prescribed TEGRETOL (generic) by the neurologist to lessen seizures. The patient''s mother also stated that the patient was still suffering from severe seizures. The outcome of grand mal seizures, mental acumen decline and "mentally challenged" was unknown. Causality was not provided. The events were considered to be disabling by the reporter. Upon internal review, the severe seizures and grand mal seizures were determined to be medically significant. Additional information has been requested.


Changed on 9/14/2017

625301 Before After
VAERS Form:(blank) 1
Age:16.0
Gender:Female
Location:Colorado
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-03-04
Entered:2016-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 1 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Electroencephalogram abnormal, Generalised tonic-clonic seizure, Mental impairment, Nuclear magnetic resonance imaging brain abnormal, Seizure, Computerised tomogram head abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Computerised tomogram, mentally challenged; Electroencephalogram, mentally challenged; Nuclear magnetic resonance imaging, mentally challenged
CDC 'Split Type': WAES1603USA001499

Write-up:Information has been received from a consumer referring to her 16 years old daughter. The patient was not pregnant. The patient had no medical history and drug reactions or allergies. On an unknown date in 2011, the patient was vaccinated with her first dose of GARDASIL (0.5 ml, lot # and expiry date unknown, intramuscular). There was no concomitant therapy reported. In 2011, almost immediately following her first intramuscular injection, the patient experienced grand mal seizures. The patient''s mother also noticed at that time that her daughter''s mental acumen began declining (The patient was previously an honor student in school). On unknown dates, the patient was vaccinated with her second and third dose of GARDASIL (0.5 ml, lot # and expiry date unknown, intramuscular). On an unknown date, the patient''s mother took the patient to a neurologist who ran a battery of tests including electroencephalogram (EEG), nuclear magnetic resonance imaging (MRI) and computerised tomogram (CAT scan). Subsequently, the test results determined the patient was "mentally challenged". In September 2014, the patient was hospitalized at a hospital for 2 days due to severe seizures (started in September 2014). The patient was also prescribed TEGRETOL (generic) by the neurologist to lessen seizures. The patient''s mother also stated that the patient was still suffering from severe seizures. The outcome of grand mal seizures, mental acumen decline and "mentally challenged" was unknown. Causality was not provided. The events were considered to be disabling by the reporter. Upon internal review, the severe seizures and grand mal seizures were determined to be medically significant. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=625301&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166